• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嵌合抗原受体T细胞治疗中的几何免疫抑制:来自数学建模的见解

Geometric immunosuppression in CAR T-cell treatment: Insights from mathematical modeling.

作者信息

Bordel-Vozmediano Silvia, Sabir Soukaina, Benito-Barca Lucía, Weigelin Bettina, Pérez-García Víctor M

机构信息

Mathematical Oncology Laboratory (MOLAB), Instituto de Matemática Aplicada a la Ciencia y la Ingeniería, Universidad de Castilla-La Mancha, Ciudad Real, 13005, Spain; Departamento de Matemáticas, Escuela Técnica Superior de Ingenieros Industriales, Universidad de Castilla-La Mancha, 13005, Ciudad Real, Spain.

Mathematical Oncology Laboratory (MOLAB), Instituto de Matemática Aplicada a la Ciencia y la Ingeniería, Universidad de Castilla-La Mancha, Ciudad Real, 13005, Spain; Departamento de Matemáticas, Escuela Técnica Superior de Ingenieros Industriales, Universidad de Castilla-La Mancha, 13005, Ciudad Real, Spain.

出版信息

Comput Biol Med. 2025 Aug;194:110427. doi: 10.1016/j.compbiomed.2025.110427. Epub 2025 Jun 11.

DOI:10.1016/j.compbiomed.2025.110427
PMID:40505286
Abstract

Chimeric antigen receptor T (CAR T) cell therapy has emerged as a promising treatment for hematological malignancies, offering a targeted approach to cancer treatment. Understanding the complexities of CAR T-cell therapy within solid tumors poses challenges due to the intricate interactions within the tumor microenvironment. Mathematical modeling may serve as a valuable tool to unravel the dynamics of CAR T-cell therapy and improve its effectiveness in solid tumors. This study aimed to investigate the impact of spatial aspects in CAR T therapy of solid tumors, utilizing cellular automata for modeling purposes. Our main objective was to deepen our understanding of treatment effects by analyzing scenarios with different spatial distributions and varying the initial quantities of tumor and CAR T-cells. Tumor geometry significantly influenced treatment efficacy in-silico, with notable differences observed between tumors with block-like arrangements and those with sparse cell distributions, leading to the concept of immune suppression due to geometrical effects. This research delves into the intricate relationship between spatial dynamics and the effectiveness of CAR T therapy in solid tumors, highlighting the relevance of tumor geometry in the outcome of cellular immunotherapy treatments. Our results provide a basis for improving the efficacy of CAR T-cell treatments by combining them with other ones reducing the density of compact tumor areas and thus opening access ways for tumor killing T-cells.

摘要

嵌合抗原受体T(CAR T)细胞疗法已成为治疗血液系统恶性肿瘤的一种有前景的方法,为癌症治疗提供了一种靶向治疗途径。由于肿瘤微环境内复杂的相互作用,了解实体瘤中CAR T细胞疗法的复杂性具有挑战性。数学建模可能是揭示CAR T细胞疗法动态并提高其在实体瘤中有效性的宝贵工具。本研究旨在利用细胞自动机进行建模,探讨实体瘤CAR T治疗中空间因素的影响。我们的主要目标是通过分析不同空间分布以及改变肿瘤和CAR T细胞初始数量的情况,加深对治疗效果的理解。肿瘤几何形状在计算机模拟中显著影响治疗效果,块状排列的肿瘤与细胞分布稀疏的肿瘤之间观察到显著差异,从而引出了几何效应导致免疫抑制的概念。本研究深入探讨了实体瘤中空间动态与CAR T治疗有效性之间的复杂关系,突出了肿瘤几何形状在细胞免疫治疗结果中的相关性。我们的结果为通过将CAR T细胞治疗与其他降低致密肿瘤区域密度从而为杀伤肿瘤的T细胞开辟通路的治疗方法相结合来提高其疗效提供了依据。

相似文献

1
Geometric immunosuppression in CAR T-cell treatment: Insights from mathematical modeling.嵌合抗原受体T细胞治疗中的几何免疫抑制:来自数学建模的见解
Comput Biol Med. 2025 Aug;194:110427. doi: 10.1016/j.compbiomed.2025.110427. Epub 2025 Jun 11.
2
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.嵌合抗原受体 (CAR) T 细胞疗法治疗复发或难治性弥漫性大 B 细胞淋巴瘤患者。
Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD013365. doi: 10.1002/14651858.CD013365.pub2.
3
A bibliometric analysis of challenges and advancements in the integrated application of nanoparticles and chimeric antigen receptor T cell therapy.纳米颗粒与嵌合抗原受体T细胞疗法联合应用的挑战与进展的文献计量分析
Hum Vaccin Immunother. 2025 Dec;21(1):2518634. doi: 10.1080/21645515.2025.2518634. Epub 2025 Jun 17.
4
Revaccination following CAR-T therapy: a needs assessment.嵌合抗原受体T细胞(CAR-T)疗法后的再次接种疫苗:需求评估
Hematology. 2025 Dec;30(1):2519865. doi: 10.1080/16078454.2025.2519865. Epub 2025 Jun 23.
5
Transduction of γδ T cells with Baboon envelope pseudotyped lentiviral vector encoding chimeric antigen receptors for translational and clinical applications.用编码嵌合抗原受体的狒狒包膜假型慢病毒载体转导γδ T细胞,用于转化研究和临床应用。
Front Immunol. 2025 Jun 6;16:1548630. doi: 10.3389/fimmu.2025.1548630. eCollection 2025.
6
Emerging combined CAR-NK cell therapies in cancer treatment: Finding a dancing partner.癌症治疗中新兴的联合CAR-NK细胞疗法:寻找舞伴。
Mol Ther. 2025 Jan 3. doi: 10.1016/j.ymthe.2024.12.057.
7
Predictive value of preclinical models for CAR-T cell therapy clinical trials: a systematic review and meta-analysis.CAR-T细胞疗法临床试验临床前模型的预测价值:一项系统评价与荟萃分析
J Immunother Cancer. 2025 Jun 12;13(6):e011698. doi: 10.1136/jitc-2025-011698.
8
B cell antigens: A key to optimizing CAR-T cell therapy.B细胞抗原:优化嵌合抗原受体T细胞疗法的关键
Int Rev Immunol. 2025 Jun 19:1-28. doi: 10.1080/08830185.2025.2515839.
9
CAR-T cell therapy for patients with hematological malignancies. A systematic review.嵌合抗原受体 T 细胞疗法治疗血液系统恶性肿瘤。系统评价。
Eur J Haematol. 2022 Dec;109(6):601-618. doi: 10.1111/ejh.13851. Epub 2022 Sep 18.
10
Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy: A Review.高肿瘤负担对嵌合抗原受体 T 细胞免疫疗法的影响:综述。
JAMA Oncol. 2024 Jan 1;10(1):115-121. doi: 10.1001/jamaoncol.2023.4504.